AURE vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a critically weak financial condition with a Piotroski F-Score of 3/9, indicating poor fundamental health. The company exhibits deeply negative profitability metrics, including a -710.49% operating margin and -1639.91% ROE, signaling severe operational inefficiency and capital destruction. Liquidity is near collapse with a current ratio of 0.10 and quick ratio of 0.02, while the negative price-to-book ratio of -73.00 suggests liabilities far exceed asset values. Despite a short-term 1-week price surge of +16.8%, the 5-year return of -98.5% underscores prolonged value erosion, and the absence of Altman Z-Score and Graham Number implies no measurable financial stability or intrinsic value support.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
AURE vs JPM: Head-to-Head Comparison
This page compares Aurelion Inc. (AURE) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.